Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |